View Rule

View EO 12866 Meetings

Printer-Friendly Version     Download RIN Data in XML

---

DOJ/DEA

RIN: 1117-AB09

Publication ID: Fall 2008

Title: Registration List Requirements for Importers and Manufactures of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine
Abstract: This rule supports those rules implementing the Combat Methamphetamine Epidemic Act of 2005 (title VII, Pub. L. 109-177) by ensuring that every location that manufactures the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, or a drug product containing ephedrine, pseudoephedrine, or phenylpropanolamine, is registered with the DEA to conduct this activity.
Agency: Department of Justice(DOJ)	Priority: Other Significant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Final Rule Stage
Major: No	Unfunded Mandates: No
CFR Citation: 21 CFR 1309
Legal Authority: 21 USC 821 to 824    21 USC 830    21 USC 871(b)    21 USC 875    21 USC 877    21 USC 958

Legal Deadline:  None

Timetable: Action Date FR Cite NPRM  01/18/2008  73 FR 3432    NPRM Comment Period End  03/18/2008     Final Action  06/00/2009

Additional Information: Docket DEA-294
Regulatory Flexibility Analysis Required: No	Government Levels Affected: None
Small Entities Affected: No	Federalism: No
Included in the Regulatory Plan: No
Public Comment URL: www.regulations.gov
RIN Data Printed in the FR: No
Related RINs: Related to 1117-AB08
Agency Contact: Mark W. Caverly Chief, Liaison and Policy Section Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7297 Email: dea.diversion.policy@usdoj.gov